Search Results for: Immunai

New Unicorns

Israel’s Hibob (see here previously), the company behind human resources management platform ‘bob’, is raising $150 million at a $1.65 billion valuation. Meanwhile Israeli biotech startup Immunai (see here previously) has raised $215 million at a valuation of just over … Continue reading

Posted in Economy & Business | Leave a comment

Investment in Israeli startups: 21/11/21

Deel raised $425 million; TripActions raised $275 million; Wiz raised $250 million; Immunai raised $215 million; Cato Networks raised $200 million; Hibob raised $150 million; Hailo raised $136 million; Arbe Robotics raised $118 million (IPO); SeaLights raised $30 million; Karma … Continue reading

Posted in Economy & Business | Leave a comment

Reprogramming the immune system

This article describes the latest progress of Israel’s Immunai (see here previously) which is mapping the immune system to help develop new life-saving treatments. It acquired US-based Dropprint Genomics and has launched into development of cancer and autoimmune disease therapies. … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Decoding the immune system

Israel’s Immunai is developing a technological platform that aims to map the entire immune system for better detection, diagnosis, and treatment of disease. It uses single cell genomics that could in the future unlock the secrets of infections, cancer and … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Investment in Israeli startups (24 May 20)

Recent startup investments include: Shopic raised $7.6 million; Xsight Labs raised $50 million; Aqua Security raised $30 million; Newsight raised $7 million; Immunai raised $20 million and Nexar raised $52 million.

Posted in Economy & Business | Leave a comment